DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DRIO is expected to report earnings to fall 242.86% to -20 cents per share on August 18
Q2'25
Est.
$-0.20
Q1'25
Beat
by $0.24
Q4'24
Beat
by $0.15
Q3'24
Beat
by $0.47
Q2'24
Beat
by $0.37
The last earnings report on May 14 showed earnings per share of 14 cents, beating the estimate of -10 cents. With 265.45K shares outstanding, the current market capitalization sits at 40.57M.